Innovent Presents Updated Results from Phase 2 Study of Dupert Fulzerasib in Advanced Non-Small Cell Lung Cancer Patients with KRAS G12C Mutation

ilikefinance06 mins

Innovent Biologics Presents Updated Results of Dupert® in NSCLC Patients at WCLC 2024 SAN FRANCISCO and SUZHOU, China, Sept. 9, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a leading biopharmaceutical company specializing in the development and commercialization of high-quality medicines, has announced the presentation of new data from a Phase 2 clinical trial…

Read More

Navigating the Pound-Sterling Rollercoaster: GBP/USD Rally Halted Near 1.29 as Trade War Anxieties Cloud the Horizon

newscaster05 mins

The Unsettling Stall in the Pound Sterling’s Rally The British Pound, represented by the symbol GBP, has seen a remarkable three-day rally, only to stall and remain below the significant resistance level of 1.2900. This level marks an important psychological and technical barrier for the currency, having served as both support and resistance numerous times…

Read More

Rocket Doctor’s Rapid Growth in Alberta: Boosting Physician Autonomy and Enhancing Healthcare Access

newsmaker04 mins

Treatment.com AI Inc.’s Rocket Doctor Expands in Alberta: Empowering Independent Physicians and Improving Patient Care Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939), a leading digital health technology company, recently announced the growth and expansion of its telemedicine platform, Rocket Doctor, in Alberta, Canada. This expansion comes as part of Treatment.com AI’s commitment to…

Read More

Important Reminder for Investors: Deadline Approaching in Lifecore Biomedical Inc. Class Action Lawsuit

newsmaker03 mins

Lifecore Biomedical, Inc. Faces Class Action Lawsuit Overview LOS ANGELES, Sept. 24, 2024 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) is reminding investors of the upcoming September 27, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Lifecore Biomedical, Inc….

Read More

Maximizing Business Success: Superior Plus Sets Date for 2024 Third Quarter Results Conference Call and Webcast

newsmaker02 mins

Superior Plus Corp. to Release 2024 Third Quarter Results Overview Superior Plus Corp. (“Superior” or “the company”) (TSX: SPB) is set to announce its financial results for the third quarter of 2024 on Wednesday, November 6, 2024, after the market closes. A conference call and webcast will be held on Thursday, November 7, 2024, at…

Read More

Is Investing in Palantir Stock Too Risky for Baby Boomers’ Retirement Funds? An In-Depth Analysis

marketinsights06 mins

Palantir Technologies: A Divisive Stock Among Investors Palantir Technologies (PLTR), a leading data analytics and software company, has been a subject of intense debate among investors due to its unique business model and controversial connections to various government agencies. Founded in 2003 by Peter Thiel and Alex Karp, Palantir has developed a suite of software…

Read More

Crypto Trader’s Underwater Fortune: How Losing $17.5M Could Mean a $25M Splash if Bitcoin Dips Below $74,000

marketsgonewild05 mins

Oh No, Another Crypto Crash! 😱 It’s a rollercoaster ride in Crypto-land once again! The recent market crash has left many investors reeling from the impact, and one such unfortunate soul is our dear friend, “Crypto-Whale” 🐳. The Unlucky Whale’s Misfortune Our dear Crypto-Whale, a seasoned trader in the crypto world, held a hefty leverage…

Read More

“Is TTD Stock a Wise Investment Before Q4 Earnings? A Comprehensive Analysis”

newscaster05 mins

The Trade Desk’s Fourth-Quarter 2024 Performance Preview The Trade Desk’s Outlook The Trade Desk, a leading technology company in the digital advertising industry, is set to announce its fourth-quarter 2024 performance. The company’s performance is likely to have benefited from the growing momentum in Connected TV (CTV) and the expansion of its partner base despite…

Read More